Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy

Abstract Background Peptide receptor radionuclide therapy is effective in treating neuroendocrine tumours, but treatment may be limited by kidney and bone marrow toxicity. In this work, the absorbed dose burden to the bone marrow was estimated using image-based dosimetry and its potential use for pr...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Märta Persson, Cecilia Hindorf, Oscar Ardenfors, Martin Larsson, Joachim N. Nilsson
Format:	Artigo
Jezik:	Inglês
Izdano:	SpringerOpen 2024-02-01
Serija:	EJNMMI Research
Teme:	Dosimetry PRRT Neuroendocrine tumours Bone marrow Toxicity
Online dostop:	https://doi.org/10.1186/s13550-024-01077-7
Oznake:	Označite Brez oznak, prvi označite!